Loading…

Hydroxymethylglutaryl co-enzyme A reductase inhibition attenuates endotoxin-mediated inflammatory responses

Background: The aim of this study was to investigate whether inhibition of hydroxymethylglutaryl co‐enzyme A reductase attenuates leucocyte–endothelial cell interactions and alters expression of endothelial constitutive nitric oxide synthase (ecNOS) and inducible nitric oxide synthase (iNOS) followi...

Full description

Saved in:
Bibliographic Details
Published in:British journal of surgery 2005-08, Vol.92 (8), p.1034-1040
Main Authors: Joyce, M., Casey, R., Gang, C., Winter, D., Kelly, C. J., Bouchier-Hayes, D. J.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3885-9c06866f5fbe30eac95b51d065816d52b8be2bb406a192b12be6f408ec13d97c3
cites
container_end_page 1040
container_issue 8
container_start_page 1034
container_title British journal of surgery
container_volume 92
creator Joyce, M.
Casey, R.
Gang, C.
Winter, D.
Kelly, C. J.
Bouchier-Hayes, D. J.
description Background: The aim of this study was to investigate whether inhibition of hydroxymethylglutaryl co‐enzyme A reductase attenuates leucocyte–endothelial cell interactions and alters expression of endothelial constitutive nitric oxide synthase (ecNOS) and inducible nitric oxide synthase (iNOS) following exposure to endotoxin. Methods: Male Sprague–Dawley rats were randomized into control, lipopolysaccharide (LPS) and pravastatin + LPS groups (seven per group). Pravastatin sodium was gavaged at 0·4 mg per kg per day for 5 days, after which LPS 15 mg/kg was administered via the jugular vein. Intravital microscopy was used to determine leucocyte–endothelial cell interactions. Results: Following the administration of LPS there was a significant reduction in leucocyte rolling velocity at 10 min (mean(s.e.m.) 69(3) versus 102(6) per cent of baseline value; P = 0·041), an increase in the number of adherent leucocytes at 10 min (4·5(0·5) versus 2·8(0·3) per 100 µm; P = 0·044) and an increase in the number of leucocytes undergoing transendothelial migration at 30 min (4·2(0·4) versus 1·7(0·4) per field; P = 0·008) compared with controls. Pretreatment with pravastatin significantly attenuated LPS‐induced leucocyte–endothelial cell interactions (rolling velocity 89(6) per cent at 10 min, P = 0·038; adherent leucocytes 3·0(0·5) per 100 µm at 10 min, P = 0·038; migrating leucocytes 1·9(0·5) per field at 30 min, P = 0·001). This endothelial protection was associated with maintenance of ecNOS and reduced iNOS expression within mesenteric tissues. Conclusion: These data show that pravastatin produces anti‐inflammatory effects in response to injurious stimuli by attenuation of leucocyte–endothelial cell interactions. Copyright © 2005 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd. Pravastatin has anti‐inflammatory effects
doi_str_mv 10.1002/bjs.4985
format article
fullrecord <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmed_primary_15931659</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BJS4985</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3885-9c06866f5fbe30eac95b51d065816d52b8be2bb406a192b12be6f408ec13d97c3</originalsourceid><addsrcrecordid>eNpFkElPwzAQhS0EgrJI_AKUC8eAl9qxj4CgrOXAdrRsZwKGLFXsioZfjyuWnp705pvRvIfQPsFHBGN6bN_D0VhJvoZGhAmeUyLkOhphjIucMMq20HYI7xgThjndRFuEK0YEVyP0cTmUfbcYGohvQ_1az6PphzpzXQ7tV3Kzk6yHcu6iCZD59s1bH33XZiZGaOcmQsigLbvYLXybN1D6ZJUJrGrTNCZ2_ZD2w6xrA4RdtFGZOsDer-6gp4vzx7PL_PZ-cnV2cps7JiXPlcNCClHxygLDYJzilpMSCy6JKDm10gK1doyFIYpaQi2IaowlOMJKVTi2gw5-7s7mNr2kZ71vUir9lzoBh7-ACc7UVW9a58OKE0oqqorE5T_cp69hWM2xXrauU-t62bo-vX5Y6or3IcLinzf9hxYFK7h-mU709O5les1vHvUz-wYGcIaU</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Hydroxymethylglutaryl co-enzyme A reductase inhibition attenuates endotoxin-mediated inflammatory responses</title><source>Oxford Journals Online</source><creator>Joyce, M. ; Casey, R. ; Gang, C. ; Winter, D. ; Kelly, C. J. ; Bouchier-Hayes, D. J.</creator><creatorcontrib>Joyce, M. ; Casey, R. ; Gang, C. ; Winter, D. ; Kelly, C. J. ; Bouchier-Hayes, D. J.</creatorcontrib><description>Background: The aim of this study was to investigate whether inhibition of hydroxymethylglutaryl co‐enzyme A reductase attenuates leucocyte–endothelial cell interactions and alters expression of endothelial constitutive nitric oxide synthase (ecNOS) and inducible nitric oxide synthase (iNOS) following exposure to endotoxin. Methods: Male Sprague–Dawley rats were randomized into control, lipopolysaccharide (LPS) and pravastatin + LPS groups (seven per group). Pravastatin sodium was gavaged at 0·4 mg per kg per day for 5 days, after which LPS 15 mg/kg was administered via the jugular vein. Intravital microscopy was used to determine leucocyte–endothelial cell interactions. Results: Following the administration of LPS there was a significant reduction in leucocyte rolling velocity at 10 min (mean(s.e.m.) 69(3) versus 102(6) per cent of baseline value; P = 0·041), an increase in the number of adherent leucocytes at 10 min (4·5(0·5) versus 2·8(0·3) per 100 µm; P = 0·044) and an increase in the number of leucocytes undergoing transendothelial migration at 30 min (4·2(0·4) versus 1·7(0·4) per field; P = 0·008) compared with controls. Pretreatment with pravastatin significantly attenuated LPS‐induced leucocyte–endothelial cell interactions (rolling velocity 89(6) per cent at 10 min, P = 0·038; adherent leucocytes 3·0(0·5) per 100 µm at 10 min, P = 0·038; migrating leucocytes 1·9(0·5) per field at 30 min, P = 0·001). This endothelial protection was associated with maintenance of ecNOS and reduced iNOS expression within mesenteric tissues. Conclusion: These data show that pravastatin produces anti‐inflammatory effects in response to injurious stimuli by attenuation of leucocyte–endothelial cell interactions. Copyright © 2005 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd. Pravastatin has anti‐inflammatory effects</description><identifier>ISSN: 0007-1323</identifier><identifier>EISSN: 1365-2168</identifier><identifier>DOI: 10.1002/bjs.4985</identifier><identifier>PMID: 15931659</identifier><identifier>CODEN: BJSUAM</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Analysis of Variance ; Animals ; Biological and medical sciences ; Cell Adhesion ; Cell Movement ; Cholesterol - blood ; Endothelial Cells - cytology ; General aspects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - toxicity ; Leukocytes - cytology ; Lipopolysaccharides - toxicity ; Male ; Medical sciences ; Mesentery - enzymology ; Nitric Oxide Synthase - metabolism ; Nitric Oxide Synthase Type II ; Nitric Oxide Synthase Type III ; Pravastatin - pharmacology ; Random Allocation ; Rats ; Rats, Sprague-Dawley</subject><ispartof>British journal of surgery, 2005-08, Vol.92 (8), p.1034-1040</ispartof><rights>Copyright © 2005 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3885-9c06866f5fbe30eac95b51d065816d52b8be2bb406a192b12be6f408ec13d97c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16989297$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15931659$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Joyce, M.</creatorcontrib><creatorcontrib>Casey, R.</creatorcontrib><creatorcontrib>Gang, C.</creatorcontrib><creatorcontrib>Winter, D.</creatorcontrib><creatorcontrib>Kelly, C. J.</creatorcontrib><creatorcontrib>Bouchier-Hayes, D. J.</creatorcontrib><title>Hydroxymethylglutaryl co-enzyme A reductase inhibition attenuates endotoxin-mediated inflammatory responses</title><title>British journal of surgery</title><addtitle>Br J Surg</addtitle><description>Background: The aim of this study was to investigate whether inhibition of hydroxymethylglutaryl co‐enzyme A reductase attenuates leucocyte–endothelial cell interactions and alters expression of endothelial constitutive nitric oxide synthase (ecNOS) and inducible nitric oxide synthase (iNOS) following exposure to endotoxin. Methods: Male Sprague–Dawley rats were randomized into control, lipopolysaccharide (LPS) and pravastatin + LPS groups (seven per group). Pravastatin sodium was gavaged at 0·4 mg per kg per day for 5 days, after which LPS 15 mg/kg was administered via the jugular vein. Intravital microscopy was used to determine leucocyte–endothelial cell interactions. Results: Following the administration of LPS there was a significant reduction in leucocyte rolling velocity at 10 min (mean(s.e.m.) 69(3) versus 102(6) per cent of baseline value; P = 0·041), an increase in the number of adherent leucocytes at 10 min (4·5(0·5) versus 2·8(0·3) per 100 µm; P = 0·044) and an increase in the number of leucocytes undergoing transendothelial migration at 30 min (4·2(0·4) versus 1·7(0·4) per field; P = 0·008) compared with controls. Pretreatment with pravastatin significantly attenuated LPS‐induced leucocyte–endothelial cell interactions (rolling velocity 89(6) per cent at 10 min, P = 0·038; adherent leucocytes 3·0(0·5) per 100 µm at 10 min, P = 0·038; migrating leucocytes 1·9(0·5) per field at 30 min, P = 0·001). This endothelial protection was associated with maintenance of ecNOS and reduced iNOS expression within mesenteric tissues. Conclusion: These data show that pravastatin produces anti‐inflammatory effects in response to injurious stimuli by attenuation of leucocyte–endothelial cell interactions. Copyright © 2005 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd. Pravastatin has anti‐inflammatory effects</description><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cell Adhesion</subject><subject>Cell Movement</subject><subject>Cholesterol - blood</subject><subject>Endothelial Cells - cytology</subject><subject>General aspects</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - toxicity</subject><subject>Leukocytes - cytology</subject><subject>Lipopolysaccharides - toxicity</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mesentery - enzymology</subject><subject>Nitric Oxide Synthase - metabolism</subject><subject>Nitric Oxide Synthase Type II</subject><subject>Nitric Oxide Synthase Type III</subject><subject>Pravastatin - pharmacology</subject><subject>Random Allocation</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><issn>0007-1323</issn><issn>1365-2168</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpFkElPwzAQhS0EgrJI_AKUC8eAl9qxj4CgrOXAdrRsZwKGLFXsioZfjyuWnp705pvRvIfQPsFHBGN6bN_D0VhJvoZGhAmeUyLkOhphjIucMMq20HYI7xgThjndRFuEK0YEVyP0cTmUfbcYGohvQ_1az6PphzpzXQ7tV3Kzk6yHcu6iCZD59s1bH33XZiZGaOcmQsigLbvYLXybN1D6ZJUJrGrTNCZ2_ZD2w6xrA4RdtFGZOsDer-6gp4vzx7PL_PZ-cnV2cps7JiXPlcNCClHxygLDYJzilpMSCy6JKDm10gK1doyFIYpaQi2IaowlOMJKVTi2gw5-7s7mNr2kZ71vUir9lzoBh7-ACc7UVW9a58OKE0oqqorE5T_cp69hWM2xXrauU-t62bo-vX5Y6or3IcLinzf9hxYFK7h-mU709O5les1vHvUz-wYGcIaU</recordid><startdate>200508</startdate><enddate>200508</enddate><creator>Joyce, M.</creator><creator>Casey, R.</creator><creator>Gang, C.</creator><creator>Winter, D.</creator><creator>Kelly, C. J.</creator><creator>Bouchier-Hayes, D. J.</creator><general>John Wiley &amp; Sons, Ltd</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200508</creationdate><title>Hydroxymethylglutaryl co-enzyme A reductase inhibition attenuates endotoxin-mediated inflammatory responses</title><author>Joyce, M. ; Casey, R. ; Gang, C. ; Winter, D. ; Kelly, C. J. ; Bouchier-Hayes, D. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3885-9c06866f5fbe30eac95b51d065816d52b8be2bb406a192b12be6f408ec13d97c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cell Adhesion</topic><topic>Cell Movement</topic><topic>Cholesterol - blood</topic><topic>Endothelial Cells - cytology</topic><topic>General aspects</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - toxicity</topic><topic>Leukocytes - cytology</topic><topic>Lipopolysaccharides - toxicity</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mesentery - enzymology</topic><topic>Nitric Oxide Synthase - metabolism</topic><topic>Nitric Oxide Synthase Type II</topic><topic>Nitric Oxide Synthase Type III</topic><topic>Pravastatin - pharmacology</topic><topic>Random Allocation</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Joyce, M.</creatorcontrib><creatorcontrib>Casey, R.</creatorcontrib><creatorcontrib>Gang, C.</creatorcontrib><creatorcontrib>Winter, D.</creatorcontrib><creatorcontrib>Kelly, C. J.</creatorcontrib><creatorcontrib>Bouchier-Hayes, D. J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>British journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Joyce, M.</au><au>Casey, R.</au><au>Gang, C.</au><au>Winter, D.</au><au>Kelly, C. J.</au><au>Bouchier-Hayes, D. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hydroxymethylglutaryl co-enzyme A reductase inhibition attenuates endotoxin-mediated inflammatory responses</atitle><jtitle>British journal of surgery</jtitle><addtitle>Br J Surg</addtitle><date>2005-08</date><risdate>2005</risdate><volume>92</volume><issue>8</issue><spage>1034</spage><epage>1040</epage><pages>1034-1040</pages><issn>0007-1323</issn><eissn>1365-2168</eissn><coden>BJSUAM</coden><abstract>Background: The aim of this study was to investigate whether inhibition of hydroxymethylglutaryl co‐enzyme A reductase attenuates leucocyte–endothelial cell interactions and alters expression of endothelial constitutive nitric oxide synthase (ecNOS) and inducible nitric oxide synthase (iNOS) following exposure to endotoxin. Methods: Male Sprague–Dawley rats were randomized into control, lipopolysaccharide (LPS) and pravastatin + LPS groups (seven per group). Pravastatin sodium was gavaged at 0·4 mg per kg per day for 5 days, after which LPS 15 mg/kg was administered via the jugular vein. Intravital microscopy was used to determine leucocyte–endothelial cell interactions. Results: Following the administration of LPS there was a significant reduction in leucocyte rolling velocity at 10 min (mean(s.e.m.) 69(3) versus 102(6) per cent of baseline value; P = 0·041), an increase in the number of adherent leucocytes at 10 min (4·5(0·5) versus 2·8(0·3) per 100 µm; P = 0·044) and an increase in the number of leucocytes undergoing transendothelial migration at 30 min (4·2(0·4) versus 1·7(0·4) per field; P = 0·008) compared with controls. Pretreatment with pravastatin significantly attenuated LPS‐induced leucocyte–endothelial cell interactions (rolling velocity 89(6) per cent at 10 min, P = 0·038; adherent leucocytes 3·0(0·5) per 100 µm at 10 min, P = 0·038; migrating leucocytes 1·9(0·5) per field at 30 min, P = 0·001). This endothelial protection was associated with maintenance of ecNOS and reduced iNOS expression within mesenteric tissues. Conclusion: These data show that pravastatin produces anti‐inflammatory effects in response to injurious stimuli by attenuation of leucocyte–endothelial cell interactions. Copyright © 2005 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd. Pravastatin has anti‐inflammatory effects</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>15931659</pmid><doi>10.1002/bjs.4985</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1323
ispartof British journal of surgery, 2005-08, Vol.92 (8), p.1034-1040
issn 0007-1323
1365-2168
language eng
recordid cdi_pubmed_primary_15931659
source Oxford Journals Online
subjects Analysis of Variance
Animals
Biological and medical sciences
Cell Adhesion
Cell Movement
Cholesterol - blood
Endothelial Cells - cytology
General aspects
Hydroxymethylglutaryl-CoA Reductase Inhibitors - toxicity
Leukocytes - cytology
Lipopolysaccharides - toxicity
Male
Medical sciences
Mesentery - enzymology
Nitric Oxide Synthase - metabolism
Nitric Oxide Synthase Type II
Nitric Oxide Synthase Type III
Pravastatin - pharmacology
Random Allocation
Rats
Rats, Sprague-Dawley
title Hydroxymethylglutaryl co-enzyme A reductase inhibition attenuates endotoxin-mediated inflammatory responses
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T01%3A06%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hydroxymethylglutaryl%20co-enzyme%20A%20reductase%20inhibition%20attenuates%20endotoxin-mediated%20inflammatory%20responses&rft.jtitle=British%20journal%20of%20surgery&rft.au=Joyce,%20M.&rft.date=2005-08&rft.volume=92&rft.issue=8&rft.spage=1034&rft.epage=1040&rft.pages=1034-1040&rft.issn=0007-1323&rft.eissn=1365-2168&rft.coden=BJSUAM&rft_id=info:doi/10.1002/bjs.4985&rft_dat=%3Cwiley_pubme%3EBJS4985%3C/wiley_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3885-9c06866f5fbe30eac95b51d065816d52b8be2bb406a192b12be6f408ec13d97c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/15931659&rfr_iscdi=true